Methylprednisolone is generally considered safe during breastfeeding, especially at low doses like 4 mg. Sulfasalazine is also typically considered safe during breastfeeding, as only minimal amounts pass into breast milk and serious adverse effects in infants are rare.
However, careful monitoring is still advised. Your treating rheumatologist likely prescribed these based on a risk-benefit analysis considering disease control.
Next Steps
- Continue breastfeeding but monitor the baby for unusual symptoms like diarrhea, rash, or jaundice.
- Inform your pediatrician about the medications for regular baby checkups.
- Stay in close follow-up with your rheumatologist to adjust medications if needed.
Health Tips
- Avoid stopping RA medications abruptly without professional guidance.
- Stay hydrated and maintain adequate rest.